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Plasmid-encoded aminoglycoside-(3)-Nacetyltransferase IV, AAC(3)-IV, was purified to homogeneity by 
affinity chromatography from E. cofi. The enzyme was shown to consist of a monomer, with the apparent 
M, being in agreement with that calculated from the nucleotide sequence of the aacC4 gene (M, 28500). 
Determination of the sequence of the N-terminal 6 amino acids revealed that processing did not occur, indi- 
cating the cytoplasmic localization of the AAC(3)-IV enzyme. A correlation of antibiotic resistance with 
K, values of the purified enzyme for a corresponding set of aminoglycoside substrates is discussed with 
respect to the mechamsm of resistance in vivo. 
Aminoglycoside-(3)-N-acetyltransferase 
1. INTRODUCTION 
Resistance to aminoglycoside antibiotics in 
gram-negative bacteria is most frequently due to 
the action of plasmid-encoded acetyl- or adenylyl- 
transferases [ 11. Some of these aminoglycoside- 
modifying enzymes have already been purified and 
characterized [1,2]. 
Recently, we cloned and sequenced the plasmid 
pWP7b encoded gene for the aminoglycoside-(3)- 
N-acetyltransferase IV, AAC(3)-IV, enzyme 
originally isolated from a Salmonella typhimurium 
strain [3]. This enzyme exhibits a broad substrate 
range, modifying gentamicin, tobramycin, 
sisomicin, netilmicin, kanamycin, neomycin and 
the unusual aminoglycoside apramycin [ 11. There 
is a considerable interest for the large-scale 
purification of an aminocyclitol-modifying en- 
zyme with a broad substrate spectrum, as is ex- 
hibited by AAC(3)-IV [1,3], for the quantitative 
determination of a number of aminoglycoside an- 
tibiotics, especially gentamicin and tobramycin, in 
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Plasmid-encoded gentamicin resistance 
body fluids [1,4]. Here the structural and kinetic 
features of the plasmid-encoded AAC(3)-IV were 
studied in order to give some insight into the 
mechanism of resistance against aminocyclitol an- 
tibiotics in gram-negative bacteria mediated by 
modifying enzymes. 
2. MATERIALS AND METHODS 
2.1. Plasmids, bacteria and growth conditions 
Plasmids pWP7b, pWP701 and pWP703, and 
Escherichia coli C600 have been described earlier 
[3]. E. coli C6OO/pWP701 was grown in a Biostat 
U50D fermenter at 37°C to late log phase in 10-l 
volumes of a complex medium consisting of 1% 
tryptone, 0.5% yeast extract, 0.2% glucose, and 
1% NaCl, buffered with 10 mM Na2HP04, 
25 mM KH2P04, 25 FM CaCl2, 250 PM MgS04, 
3 mM (NH&S04, and supplemented with 
10 pg/ml gentamicin. 
2.2. Purification of AAC(3)-IV 
All operations were carried out at 4°C. 
Ribosome-free supernatants (SlOO) of 80 g E. cofi 
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C6OO/pWP701 were prepared by disrupting cells 
by a French pressure cell at 16000 lb/inch’, and 
centrifugation (1 h, 100000 x g) in buffer (20 rnM 
Tris-Cl, pH 7.5, 10 mM MgC12, 30 mM NHXl, 
6 mM 2-mercaptoethanol). Enriched AAC(3)-IV 
enzyme was obtained by affinity chromatography 
with CH-Sepharose to which tobramycin had been 
covalently coupled as described by the manufac- 
turer (Pharmacia). The SlOO was concentrated by 
precipitation with 65% ammonium sulfate, dia- 
lyzed against 10 mM Tris-Cl, pH 7.6 (buffer A), 
and applied to a 0.7 x 25 cm tobramycin-sepha- 
rose column (flow rate 10 ml/h; fraction size 
2.3 ml). After washing with buffer A there 
was a first elution step with buffer B (100 mM 
(NHd)$SOd in buffer A) and a second with buffer 
C (5 ml 20 mg/ml gentamicin in buffer A) and 
washing with buffer A. Purified AAC(3)-IV 
enzyme was lyophilized and stored at -20°C. 
Aminoglycoside acetyltransferase activity and pro- 
tein concentrations were determined according to 
[5,6]. Gel electrophoresis was performed as de- 
scribed in [7,8]. 
2.3. Characterization of the AAC(3)-IV enzyme 
Partial proteolysis with Staphylococcus aureu.s 
V8 protease was carried out according to [9], and 
analysis of the amino acid sequence of the purified 
AAC(3)-IV enzyme according to the ‘DABITC- 
method as described in [lo]. For the determination 
of the M, of the native enzyme, gel filtration using 
a 2.5 x 120 cm sephacryl S300 column was per- 
formed (running buffer: 0.1 M KH~PO~/K~HPOI, 
pH 7.5; flow rate 23 ml/h). 
2.4. mic values 
Minimal inhibitory concentrations (mic) were 
determined for E. coli C600/pWP7b according to 
[ll] using 0, 1.6, 3.1, 6.2, 12.5, 25, 50, 100, 200 
and 400 pg/ml of aminoglycoside antibiotics. 
3. RESULTS AND DISCUSSION 
3.1. Purification of the AAC(3)-IV enzyme 
A typical result of a purification procedure of 
the AAC(3)-IV enzyme from E. coli 
C6OO/pWP701 is summarized in table 1. The bulk 
of the SlOO proteins did not bind to the 
tobramycin-Sepharose column and eluted by 
washing with buffer A. A minor fraction of the 
AAC(3)-IV enzyme was eluted with buffer B 
together with residual non-specifically bound pro- 
tein, whereas specifically bound aminocyclitol 
acetyltransferase was removed from the column by 
buffer C. The quite unusual elution behaviour of 
the AAC(3)-IV enzyme could probably be at- 
tributed to the fact that different primary amino 
residues of the tobramycin molecule had been 
covalently coupled to the Sepharose matrix thus 
resulting in heterogenous binding affinities of the 
AAC(3)-IV enzyme. Moreover, aminoglycoside 
Sepharose was described to act as anion exchange 
material because of the polycationic nature of 
these antibiotics [l]. However, the AAC(3)-IV en- 
zyme, which was found to comprise at least 1% of 
the SlOO proteins (fig.lA) was enriched 63-fold by 
affinity chromatography (table 1). 
One-dimensional SDS-gel electrophoresis reveal- 
ed that the purified enzyme consisted of two 
molecular species with apparent M, of 27500 and 
29500, respectively (fig.lB); no other protein 
species were detectable. Two-dimensional gel elec- 
trophoresis [8] of the purified enzyme resulted in 
Table 1 
Purification of the AAC(3)-IV enzyme 
Step Total Total 
protein activity 
(mg) bkat) 
Specific 
activity 
&kat/ 
mg protein) 
Recovery 
(To) 
Purifi- 
cation 
(-fold) 
1. SlOO 
2. Tobramycin-Sepharose, 
elution with (NH&S04 
3. Tobramycin-Sepharose, 
elution with gentamicin 
2700 87 0.032 100 1 
390 39 0.1 45 3.1 
6 12 2.0 14 63 
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Fig.1. Gel electrophoretic mobility of the AAC(3)-IV 
enzyme. One-dimensional SDS-polyacrylamide gel 
electrophoresis [7] of (A) SlOO of E. coli C6OO/pWP701, 
and (B) purified AAC(3)-IV enzyme. (C) Two- 
dimensional gel electrophoresis of a total cell extract of 
strain E. coli C6OO/pWP703 according to O’Farrell [8]. 
Arrows indicate the two polypeptide forms of the 
enzyme; b, mature form of ,&lactamase [3]. 
two spots (not shown) with identical isoelectric 
points and M, values corresponding to those 
observed in one-dimensional gels. Separation of an 
extract of E. coli C6OO/pWP703 (fig.lC) by the 
same system allowed estimation of the isoelectric 
points to be about 5.6 when other E. coli proteins 
identified on O’Farrell gels [12] or the slightly 
more acidic TEM- 1 ,&-lactamase [ 131 were used as 
internal standards. 
There are a number of possible explanations for 
the occurrence of two bands in SDS-gel elec- 
trophoresis: (i) Enrichment of two different 
cellular proteins by affinity chromatography, one 
of which exhibits aminocyclitol acetyltransferase 
activity, (ii) the AAC(3)-IV enzyme consists of two 
subunits, (iii) processing or modification of a 
precursor, (iv) partial degradation by proteases, (v) 
premature termination or partial ‘read-through’ 
through a stop-codon, (vi) alternate usage of a dif- 
ferent reading frame, or (vii) different migration 
behaviour of two stable conformations of the 
AAC(3)-IV enzyme in the presence of SDS. The 
following findings support the last mentioned ex- 
planation: (i) When either of the two bands in SDS 
gels were rerun with the same method again a 
separation into two bands occurred. (ii) Expression 
of plasmid pWP701 in minicells [3] resulted in the 
same products as were observed by gel elec- 
trophoresis of the purified AAC(3)-IV enzyme. 
(iii) DNA sequence analysis of the aacC4 gene 
[3,1 l] revealed that there is only one open reading 
frame coding for a protein with M, 28500, which 
is in good agreement with the size of the two pro- 
ducts of the AAC(3)-IV enzyme determined by gel 
electrophoresis. The derived amino acid sequence 
for the acetyltransferase does not contain a typical 
procaryotic signal sequence [14]. The sequence of 
the N-terminal 6 amino acids of the AAC(3)-IV en- 
zyme was determined to be (NHz)-Met-Gln-Tyr- 
Glu-Trp-Arg . . . -(COOH), which corresponds to 
the one proposed from the DNA sequence for the 
aacC4 gene [ 111. N-terminal processing did not oc- 
cur except for the removal of the formyl residues 
from methionine which resulted in covalent coupl- 
ing of the protein to isothiocyanate compounds. 
(iv) Partial proteolysis with S. aureus VS protease 
yielded the same pattern of peptides for the two 
proteins when isolated from SDS gels (not shown). 
These results agree with the suggested two confor- 
mational forms of the AAC(3)-IV enzyme in 
polyacrylamide gels. Nevertheless, for a final con- 
clusion further data disproving other explanations 
such as C-terminal processing are required. 
In the past, there has been discussion on the 
localization to the periplasmic space of 
aminoglycoside modifying enzymes in gram- 
negative bacteria [l]. Recently, the presence of an 
amikacin phosphorylating enzyme, APH(6’), in 
the cytoplasm was shown [15]. The absence of a 
signal sequence and of N-terminal processing in- 
dicated that the AAC(3)-IV enzyme was similarly 
localized in the cytoplasm. Also, there is no 
evidence for a characteristic signal sequence [14] 
usually found at the N-terminus of excreted pro- 
teins for any of the already sequenced 
aminoglycoside resistance genes [ 11,171. Taken 
together, these results support a cytoplasmic 
localization of aminocyclitol-modifying enzymes 
in general. 
3.2. Structural and kinetic features of the 
AAC(3)-IV enzyme 
Gel filtration showed that the purified AAC(3)- 
IV enzyme was monomeric under the tested condi- 
tion (not shown; see section 2). Acetyltransferase 
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Gentamicin (complex) 177 
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Tobramycin 26 
Apramycin 11 
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